SEARCH

SEARCH BY CITATION

REFERENCES

  • Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD, Sallan SE, Lander ES, Golub TR, Korsmeyer SJ. 2002. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30:4147.
  • Bach C, Buhl S, Mueller D, Garcia-Cuellar MP, Maethner E, Slany RK. 2010. Leukemogenic transformation by HOXA cluster genes. Blood 115:29102918.
  • Bain G, Engel I, Robanus Maandag EC, te Riele HP, Voland JR, Sharp LL, Chun J, Huey B, Pinkel D, Murre C. 1997. E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol 17:47824791.
  • Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885892.
  • Bayly R, Chuen L, Currie RA, Hyndman BD, Casselman R, Blobel GA, LeBrun DP. 2004. E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells. J Biol Chem 279:5536255371.
  • Bayly R, Murase T, Hyndman BD, Savage R, Nurmohamed S, Munro K, Casselman R, Smith SP, LeBrun DP. 2006. Critical role for a single leucine residue in leukemia induction by E2A-PBX1. Mol Cell Biol 26:64426452.
  • Bijl J, Krosl J, Lebert-Ghali CE, Vacher J, Mayotte N, Sauvageau G. 2008. Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia. Oncogene.
  • Bijl J, Sauvageau M, Thompson A, Sauvageau G. 2005. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia. Genes Dev 19:224233.
  • Chang CP, Brocchieri L, Shen WF, Largman C, Cleary ML. 1996. Pbx modulation of Hox homeodomain amino-terminal arms establishes different DNA-binding specificities across the Hox locus. Mol Cell Biol 16:17341745.
  • Chang CP, De, V, I and Cleary ML. 1997. The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis. Mol Cell Biol 17:8188.
  • Chang CP, Shen WF, Rozenfeld S, Lawrence HJ, Largman C, Cleary ML. 1995. Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins. Genes Dev 9:663674.
  • Choe SK, Lu P, Nakamura M, Lee J, Sagerstrom CG. 2009. Meis cofactors control HDAC and CBP accessibility at Hox-regulated promoters during zebrafish embryogenesis. Dev Cell 17:561567.
  • de Lau WB, Hurenkamp J, Berendes P, Touw IP, Clevers HC, van Dijk MA. 1998. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1. Oncogene 17:503510.
  • Dickson GJ, Lappin TR, Thompson A. 2009. Complete array of HOX gene expression by RQ-PCR. Methods Mol Biol 538:369393.
  • Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, Look AT. 2003. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 102:262268.
  • Fischbach NA, Rozenfeld S, Shen W, Fong S, Chrobak D, Ginzinger D, Kogan SC, Radhakrishnan A, Le Beau MM, Largman C, Lawrence HJ. 2005. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. Blood 105:14561466.
  • Fournier M, Lebert-Ghali CE, Krosl G, Bijl JJ. 2012. HOXA4 induces expansion of hematopoietic stem cells in vitro and confers enhancement of pro-B-cells in vivo. Stem Cells Dev 21:133142.
  • Gwin K, Frank E, Bossou A, Medina KL. 2010. Hoxa9 regulates Flt3 in lymphohematopoietic progenitors. J Immunol 185:65726583.
  • Huang Y, Sitwala K, Bronstein J, Sanders D, Dandekar M, Collins C, Robertson G, MacDonald J, Cezard T, Bilenky M, Thiessen N, Zhao Y, Zeng T, Hirst M, Hero A, Jones S, Hess JL. 2012. Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood 119:388398.
  • Kamps MP, Baltimore D. 1993. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol Cell Biol 13:351357.
  • Kamps MP, Look AT, Baltimore D. 1991. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev 5:358368.
  • Kamps MP, Murre C, Sun XH, Baltimore D. 1990. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60:547555.
  • Kamps MP, Wright DD, Lu Q. 1996. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation. Oncogene 12:1930.
  • Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg AM, Sauvageau G. 1998. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 17:37143725.
  • Lawrence HJ, Helgason CD, Sauvageau G, Fong S, Izon DJ, Humphries RK, Largman C. 1997. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89:19221930.
  • Lebert-Ghali CE, Fournier M, Dickson GJ, Thompson A, Sauvageau G, Bijl JJ. 2010. HoxA cluster is haploinsufficient for activity of hematopoietic stem and progenitor cells. Exp Hematol 38:10741086.
  • Lu Q, Kamps MP. 1997. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo. Oncogene 14:7583.
  • Lu Q, Knoepfler PS, Scheele J, Wright DD, Kamps MP. 1995. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes. Mol Cell Biol 15:37863795.
  • Lu Q, Wright DD, Kamps MP. 1994. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol Cell Biol 14:39383948.
  • Mandal M, Powers SE, Ochiai K, Georgopoulos K, Kee BL, Singh H, Clark MR. 2009. Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nat Immunol 10:11101117.
  • Markowitz D, Hesdorffer C, Ward M, Goff S, Bank A. 1990. Retroviral gene transfer using safe and efficient packaging cell lines. Ann N Y Acad Sci 612:407414.
  • Mazieres J, You L, He B, Xu Z, Lee AY, Mikami I, McCormick F, Jablons DM. 2005. Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene 24:53965400.
  • McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C. 1999. Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. Proc Natl Acad Sci U S A 96:1146411469.
  • Monica K, LeBrun DP, Dedera DA, Brown R, Cleary ML. 1994. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol 14:83048314.
  • Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, Cleary ML. 1990. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535545.
  • Perkins AC, Cory S. 1993. Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene. EMBO J 12:38353846.
  • Phelan ML, Rambaldi I, Featherstone MS. 1995. Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif. Mol Cell Biol 15:39893997.
  • Quong MW, Romanow WJ, Murre C. 2002. E protein function in lymphocyte development. Annu Rev Immunol 20:301322.
  • Reya T, O'Riordan M, Okamura R, Devaney E, Willert K, Nusse R, Grosschedl R. 2000. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13:1524.
  • Sagerstrom CG. 2004. PbX marks the spot. Dev Cell 6:737738.
  • Saleh M, Rambaldi I, Yang XJ, Featherstone MS. 2000. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. Mol Cell Biol 20:86238633.
  • Sauvageau G, Lansdorp PM, Eaves CJ, Hogge DE, Dragowska WH, Reid DS, Largman C, Lawrence HJ, Humphries RK. 1994. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc Natl Acad Sci U S A 91:1222312227.
  • Sauvageau G, Thorsteinsdottir U, Hough MR, Hugo P, Lawrence HJ, Largman C, Humphries RK. 1997. Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. Immunity 6:1322.
  • Staal FJ, Clevers HC. 2005. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol 5:2130.
  • Sykes DB, Kamps MP. 2004. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice. Mol Cell Biol 24:12561269.
  • Thompson A, Quinn MF, Grimwade D, O'Neill CM, Ahmed MR, Grimes S, McMullin MF, Cotter F, Lappin TR. 2003. Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR. Blood 101:15581565.
  • Thorsteinsdottir U, Kroon E, Jerome L, Blasi F, Sauvageau G. 2001. Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia. Mol Cell Biol 21:224234.
  • Thorsteinsdottir U, Krosl J, Kroon E, Haman A, Hoang T, Sauvageau G. 1999. The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells. Mol Cell Biol 19:63556366.
  • Thorsteinsdottir U, Mamo A, Kroon E, Jerome L, Bijl J, Lawrence HJ, Humphries K, Sauvageau G. 2002. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99:121129.
  • Thorsteinsdottir U, Sauvageau G, Hough MR, Dragowska W, Lansdorp PM, Lawrence HJ, Largman C, Humphries RK. 1997. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol Cell Biol 17:495505.
  • van Dijk MA, Voorhoeve PM, Murre C. 1993. Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia. Proc Natl Acad Sci U S A 90:60616065.
  • van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A. 1991. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 65:737752.
  • Volpe G, Walton DS, Del Pozzo W, Garcia P, Dasse E, O'Neill LP, Griffiths M, Frampton J, Dumon S. 2013. C/EBPalpha and MYB regulate FLT3 expression in AML. Leukemia 27:14871496.
  • Wang GG, Pasillas MP, Kamps MP. 2006. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes. Mol Cell Biol 26:39023916.
  • Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, Zon LI, Armstrong SA. 2010. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 327:16501653.
  • Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L, Downing JR. 2002. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1:133143.